Dr. Todd B. Mendelson, MD
Cardiac Electrophysiology (Clinical Cardiac Electrophysiology Physician)
3400 Spruce St, Hospital Of The University Of Pennsylvania
Philadelphia, PA 19104
- Medicare participating
At a glance
- Medical school
- Perelman School of Med at the University of Pennsylvania (2009)
- Years since graduation
- 17
- In the NPI registry since
- 2009
- Medicare patients seen, 2024
- 898
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2009Medical school: Perelman School of Med at the University of Pennsylvania
- 2009Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Clinical Cardiac Electrophysiology Physician primary
PA license MD454835 -
Cardiovascular Disease Physician
PA license MD454835
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Hospital of Univ of Pennsylvania Philadelphia, PA
- Penn Presbyterian Medical Center Philadelphia, PA
- Shore Medical Center Somers Point, NJ
Medical groups
- Clinical Health Care Associates of New Jersey PC (797 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 898
- Services billed
- 2,781
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 448 | 329 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 296 | 231 |
| Established patient office or other outpatient visit, 40-54 minutes | 256 | 207 |
| Established patient office or other outpatient visit, 30-39 minutes | 133 | 115 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 72 | 67 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 71 | 66 |
| Programming of dual lead pacemaker system | 60 | 46 |
| External shock to heart to regulate heart beat | 38 | 34 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 37 | 28 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 35 | 35 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Eliquis (apixaban) Other prescribers in Philadelphia, PA | 200 |
| Metoprolol Succinate Other prescribers in Philadelphia, PA | 105 |
| Amiodarone Hcl Other prescribers in Philadelphia, PA | 79 |
| Xarelto (rivaroxaban) Other prescribers in Philadelphia, PA | 74 |
| Sotalol (sotalol hcl) Other prescribers in Philadelphia, PA | 60 |
| Dofetilide | 60 |
| Metoprolol Tartrate Other prescribers in Philadelphia, PA | 48 |
| Flecainide Acetate Other prescribers in Philadelphia, PA | 38 |
| Atorvastatin Calcium Other prescribers in Philadelphia, PA | 34 |
| Amlodipine Besylate Other prescribers in Philadelphia, PA | 34 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 6 companies reported 8 payments worth $252 in total to this clinician.
| Biotronik Inc. | $85.63 |
|---|---|
| Abbott Laboratories | $67.08 |
| Impulse Dynamics (USA) Inc. | $43.75 |
| Heartflow, Inc. | $19.64 |
| Medtronic, Inc. | $18.99 |
| Zoll Services LLC (a/k/a Zoll Lifecor Corp) | $16.74 |
| Food and Beverage | $252 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $28,842 in research payments for these studies, mostly to the institutions running them.
- Double-blind, Randomized, Placebo-controlled Study Evaluating Efficacy and Safety of IgPro20 in Post-COVID-19 POTS
Csl Behring · Terminated · NCT06524739
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.